Elevance Health, Inc. (ELV)
What changed this quarter
- Risk factors — 1 added · new: We are subject to risks associated with pan…
What changed in recent SEC filings — factual, not a buy/sell recommendation.
Company overview
Elevance Health (formerly Anthem). A large US health-insurance company. It holds over 40 million members via the Blue Cross Blue Shield network.
What is the Biotech & Health sector?
Pharma, biotech, and medical devices. Driven by trial-result events.
Elevance Health, Inc. is classified under the Biotech & Health sector. See peers below.
Elevance Health, Inc. key financials
Based on SEC filings · latest quarter (TTM)
Tap a metric name to see its meaning in the glossary.
ETFs holding Elevance Health, Inc.
Per SEC N-PORT · 2026-03-31 · by weight · factual
ELV on Stocklore
- Revenue by segment — segment weights verified from SEC filings, YoY changes, growth drivers and concentration
- Financials & earnings quality — 6 metrics (FCF conversion, ROIC, net debt, etc.) to gauge profit quality
- 13F institutional holdings — holdings and weight changes of major institutions (45-day delay)
- Sector-relative metrics — valuation and growth vs the Biotech & Health average
Peers · Biotech & Health
ELV FAQ
What is Elevance Health, Inc. (ELV)?
Elevance Health (formerly Anthem). A large US health-insurance company. It holds over 40 million members via the Blue Cross Blue Shield network.
What sector is Elevance Health, Inc. in?
Elevance Health, Inc. is classified under Biotech & Health. Pharma, biotech, and medical devices. Driven by trial-result events.
What are Elevance Health, Inc.'s key financials?
Based on the latest quarter (TTM) from SEC filings: Revenue growth (YoY) 6.3%, Operating margin 3.5%, Net margin 2.5%, ROE 12.9%, Debt-to-equity 0.73x. Definitions and interpretation are available on Stocklore.
Where can I analyze Elevance Health, Inc. (ELV) stock?
On Stocklore you can see ELV's financials & earnings quality, 13F institutional holdings, and sector-relative metrics in one place. This page is for information and tools — not a buy/sell recommendation.
Data sources: SEC EDGAR (financials & filings), 13F (institutional holdings, 45-day delay), market data. This page is for information and analysis tools — it does not recommend buying or selling any security. Investment decisions and responsibility are your own.